Bloomberg GSK Plc and CureVac NV are planning further patient trials of their messenger RNA vaccines for flu and Covid-19 after promising early results, though the partners still lag behind rivals in the race to expand use of mRNA technology. The partners’ second-generation vaccine candidates showed promising abilities to spur the immune system in early-stage trials, CureVac said. The …

Bloomberg Euro-area inflation returned to single digits for the first time since August, fuelling hopes that the bloc’s worst-ever spike in consumer prices has peaked. December’s reading came in at 9.2%, Eurostat said, with slower growth in energy costs the only reason for the moderation. The figure reflects slowdowns in Germany, France, Italy and Spain and was less than the …

  Bloomberg China’s equities are poised to claim back a one-third weighting in a benchmark emerging-markets index, following a sharp outperformance sparked by an easing of strict Covid-19 curbs and a pivot to pro-growth policies. Stocks listed in the mainland and Hong Kong now account for 32.2% of the MSCI Emerging Markets Index, up from 26.8% in October. The MSCI …